Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,921 | 6 | 73.7% |
| Food and Beverage | $686.81 | 35 | 26.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $2,048 | 8 | $0 (2022) |
| ABBVIE INC. | $156.70 | 9 | $0 (2023) |
| Allergan, Inc. | $81.03 | 5 | $0 (2022) |
| Scilex Pharmaceuticals Inc. | $67.34 | 4 | $0 (2023) |
| SI-BONE, INC. | $55.67 | 3 | $0 (2024) |
| Lilly USA, LLC | $32.73 | 2 | $0 (2021) |
| DePuy Synthes Sales Inc. | $27.63 | 1 | $0 (2022) |
| Averitas Pharma Inc. | $24.29 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $19.78 | 1 | $0 (2017) |
| Lundbeck LLC | $18.14 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.00 | 3 | Averitas Pharma Inc. ($24.29) |
| 2023 | $68.90 | 4 | SI-BONE, INC. ($35.88) |
| 2022 | $1,706 | 16 | Stryker Corporation ($1,507) |
| 2021 | $672.54 | 11 | Stryker Corporation ($524.76) |
| 2020 | $17.22 | 1 | Allergan, Inc. ($17.22) |
| 2019 | $22.96 | 2 | Flexion Therapeutics, Inc. ($11.65) |
| 2018 | $14.39 | 1 | Allergan Inc. ($14.39) |
| 2017 | $48.51 | 3 | Daiichi Sankyo Inc. ($19.78) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $13.92 | General |
| 07/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/03/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $19.79 | General |
| 09/11/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $12.71 | General |
| 04/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Analgesic | ||||||
| 02/28/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| 07/28/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/04/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $14.53 | General |
| 04/25/2022 | Stryker Corporation | SPINEJACK (Device) | Travel and Lodging | Cash or cash equivalent | $174.77 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/22/2022 | Stryker Corporation | SPINEJACK (Device) | Travel and Lodging | Cash or cash equivalent | $230.45 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/22/2022 | Stryker Corporation | SPINEJACK (Device) | Travel and Lodging | Cash or cash equivalent | $154.31 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/18/2022 | Stryker Corporation | SPINEJACK (Device) | Travel and Lodging | Cash or cash equivalent | $198.58 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/30/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 03/29/2022 | Stryker Corporation | SPINEJACK (Device) | Travel and Lodging | Cash or cash equivalent | $749.27 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/06/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.14 | General |
| Category: NEUROLOGY | ||||||
| 03/03/2022 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Sports Early Intervention | ||||||
| 02/24/2022 | Scilex Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 01/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/18/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 609 | 1,247 | $249,081 | $67,147 |
| 2022 | 21 | 705 | 1,610 | $307,946 | $81,975 |
| 2021 | 20 | 931 | 3,170 | $356,416 | $109,609 |
| 2020 | 20 | 874 | 2,813 | $362,018 | $97,157 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 283 | $51,506 | $16,533 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 111 | $29,859 | $10,629 | 35.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 58 | 85 | $27,975 | $8,073 | 28.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 33 | 50 | $36,540 | $7,449 | 20.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 68 | 76 | $26,412 | $6,528 | 24.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 53 | 76 | $16,608 | $4,094 | 24.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 38 | 39 | $10,257 | $2,757 | 26.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 51 | 57 | $8,653 | $2,235 | 25.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 28 | 47 | $10,612 | $2,183 | 20.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 12 | 18 | $6,867 | $2,081 | 30.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 31 | 32 | $8,800 | $2,029 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,573 | $1,184 | 25.9% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 18 | $3,912 | $1,177 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 15 | $994.00 | $165.30 | 16.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 305 | $3,969 | $22.96 | 0.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 18 | $1,544 | $7.85 | 0.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 402 | $73,164 | $24,410 | 33.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 44 | 69 | $55,713 | $9,922 | 17.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 56 | 91 | $23,055 | $7,549 | 32.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 62 | 69 | $20,854 | $6,774 | 32.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 53 | 87 | $13,271 | $4,121 | 31.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2022 | 22 | 39 | $12,037 | $3,662 | 30.4% |
| 64625 | Destruction of nerves supplying joint between spine and pelvis using imaging guidance | Facility | 2022 | 14 | 23 | $11,408 | $3,409 | 29.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 44 | 45 | $11,529 | $3,056 | 26.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2022 | 37 | 39 | $10,725 | $3,056 | 28.5% |
About Dr. Mandeep Othee, M.D
Dr. Mandeep Othee, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Odessa, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295850436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mandeep Othee, M.D has received a total of $2,608 in payments from pharmaceutical and medical device companies, with $58.00 received in 2024. These payments were reported across 41 transactions from 16 companies. The most common payment nature is "Travel and Lodging" ($1,921).
As a Medicare-enrolled provider, Othee has provided services to 3,119 Medicare beneficiaries, totaling 8,840 services with total Medicare billing of $355,888. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Pain Medicine
- Location Odessa, TX
- Active Since 03/20/2007
- Last Updated 12/27/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1295850436
Products in Payments
- SPINEJACK (Device) $1,921
- UBRELVY (Drug) $118.70
- MULTIGEN 2 (Device) $110.82
- BOTOX (Biological) $82.77
- EMGALITY (Drug) $32.73
- MONOVISC (Device) $27.63
- QUTENZA (Drug) $24.29
- QULIPTA (Drug) $21.87
- Movantik (Drug) $19.78
- ZTLido (Drug) $19.37
- VYEPTI (Biological) $18.14
- IVS - MultiGen 2RF (Device) $16.24
- Licart (Drug) $14.96
- BOTOX THERAPEUTIC (Biological) $14.39
- LYRICA (Drug) $12.49
- BRIDION (Drug) $12.11
- Zilretta (Drug) $11.65
- AIMOVIG (Biological) $11.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Odessa
Dr. Susan Van De Water, Md, MD
Physical Medicine & Rehabilitation
Mr. Alvin Costales
Physical Medicine & Rehabilitation
Renee Elston, Pta, PTA
Physical Medicine & Rehabilitation
Kandance Hillis, Pta, PTA
Physical Medicine & Rehabilitation
Doreen Slough, Pta, PTA
Physical Medicine & Rehabilitation
Mr. Bienvenido Levardo, Pt, PT
Physical Medicine & Rehabilitation